Alectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study - Concepedia

Concepedia

Publication | Open Access

Alectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study

DOI Full Paper Access

14

Citations

0

References

2017

Year

Shirish M. Gadgeel, Solange Peters, Tony Mok, Alice T. Shaw, Dongwook Kim, S-H.I. Ou, M. Pérol, Rafał Dziadziuszko, Jin Seok Ahn, Rafael Rosell,

Annals of Oncology

PharmacologyPharmacotherapyAlex StudyInnovative TreatmentMedicineNovel TherapyTreatment DevelopmentAlectinib Vs CrizotinibTreatment-naïve Alk+ Nsclc

No additional data available for this publication yet. Check back later!